Loading...

Sonic Healthcare Limited

SHL.AXASX
HealthcareMedical - Diagnostics & Research
$26.20
$-0.07(-0.27%)

Sonic Healthcare Limited (SHL.AX) Stock Overview

Explore Sonic Healthcare Limited’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
12.17%
12.17%
Profit Growth
$1.13
25.39%
EPS Growth
$1.13
26.71%
Operating Margin
30.28%
0.47%
ROE
6.77%
25.39%
Dividend Yield
0.00%
2.59%
Analyst Recommendations data is not available for SHL.AXAnalyst Recommendations details for SHL.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

CEO

Dr. Colin Stephen Goldschmidt F.A.C.I.D., F.A.I.C.D., F.R.C.P.A., M.B.B.Ch.

Employees

42,000

Headquarters

Grosvenor Place, Sydney, NSW

Founded

1999

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.